Literature DB >> 7853541

Interleukin-12 gene expression after viral infection in the mouse.

J P Coutelier1, J Van Broeck, S F Wolf.   

Abstract

Interleukin-12 is a lymphokine that triggers gamma interferon secretion by various cells and differentiation of T-helper lymphocytes towards the Th1 subtype. Since viruses are potent inducers of gamma interferon production and elicit immune responses most probably mediated by Th1 cells, like B-cell immunoglobulin G2a secretion, we analyzed interleukin-12 message expression after infection of mice with lactate dehydrogenase-elevating virus, mouse hepatitis virus, and mouse adenovirus. Our results indicated that the message for the p40 component of interleukin-12 was transiently increased shortly after infection. Interleukin-12 was expressed mainly by macrophages. Therefore, production of interleukin-12 might constitute the initial event that would determine the subsequent characteristics of the immune response elicited by viral infections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853541      PMCID: PMC188815     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Polyclonal B cell activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase-elevating virus is partly dependent on CD4+ lymphocytes.

Authors:  X Li; B Hu; J Harty; C Even; P G Plagemann
Journal:  Viral Immunol       Date:  1990       Impact factor: 2.257

2.  Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma.

Authors:  M A Jutila; F G Kroese; K L Jutila; A M Stall; S Fiering; L A Herzenberg; E L Berg; E C Butcher
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

Review 3.  The LY-6 locus: a multigene family encoding phosphatidylinositol-anchored membrane proteins concerned with T-cell activation.

Authors:  K L Rock; H Reiser; A Bamezai; J McGrew; B Benacerraf
Journal:  Immunol Rev       Date:  1989-10       Impact factor: 12.988

4.  Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.

Authors:  A S Stern; F J Podlaski; J D Hulmes; Y C Pan; P M Quinn; A G Wolitzky; P C Familletti; D L Stremlo; T Truitt; R Chizzonite
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts.

Authors:  K L Holmes; W Y Langdon; T N Fredrickson; R L Coffman; P M Hoffman; J W Hartley; H C Morse
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

6.  Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus.

Authors:  J P Coutelier; J Van Snick
Journal:  Eur J Immunol       Date:  1985-03       Impact factor: 5.532

7.  In vivo polyclonal B-lymphocyte activation elicited by murine viruses.

Authors:  J P Coutelier; P G Coulie; P Wauters; H Heremans; J T van der Logt
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Virally induced modulation of murine IgG antibody subclasses.

Authors:  J P Coutelier; J T van der Logt; F W Heessen; A Vink; J van Snick
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

9.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  IgG2a restriction of murine antibodies elicited by viral infections.

Authors:  J P Coutelier; J T van der Logt; F W Heessen; G Warnier; J Van Snick
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

View more
  33 in total

1.  Dysregulation in IL-12 secretion by neutrophils from HIV-infected patients.

Authors:  A Vecchiarelli; C Monari; B Palazzetti; F Bistoni; A Casadevall
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue.

Authors:  Samantha R Stubblefield Park; Mi Widness; Alan D Levine; Catherine E Patterson
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro.

Authors:  N Bhardwaj; R A Seder; A Reddy; M V Feldman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.

Authors:  L Pitzurra; R Cherniak; M Giammarioli; S Perito; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections.

Authors:  J A Carr; J Rogerson; M J Mulqueen; N A Roberts; R F Booth
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Role of interleukin-12 in primary influenza virus infection.

Authors:  J M Monteiro; C Harvey; G Trinchieri
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 7.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

8.  Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection.

Authors:  L P Cousens; J S Orange; H C Su; C A Biron
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

9.  CpG oligodeoxynucleotides accelerate reovirus type 2-triggered insulitis in DBA/1 suckling mice.

Authors:  T Hayashi; K Yoshinaka; K Hasegawa; K Maeda; T Onodera
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

10.  Mouse adenovirus type 1 infection of natural killer cell-deficient mice.

Authors:  Amanda R Welton; Lisa E Gralinski; Katherine R Spindler
Journal:  Virology       Date:  2007-12-21       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.